Topiroxostat is a potent xanthine oxidase inhibitor used to treat hyperuricemia and gout by suppressing the production of uric acid. This category provides a comprehensive range of analytical tools essential… Read more






Topiroxostat is a potent xanthine oxidase inhibitor used to treat hyperuricemia and gout by suppressing the production of uric acid. This category provides a comprehensive range of analytical tools essential for pharmaceutical development, including Topiroxostat reference standards, related impurities, and stable isotope-labelled compounds. Laboratories utilize these high-quality materials for critical analytical testing, such as method validation, stability studies, and routine quality control. Impurity profiling is streamlined through the availability of both pharmacopeial and non-pharmacopeial impurities, allowing for accurate identification and quantification of degradation products or synthesis by-products. Furthermore, stable isotope-labelled standards, such as deuterated analogues, serve as precise internal standards for mass spectrometry-based assays. By providing these essential compounds, this collection supports rigorous characterization protocols, ensuring adherence to the strict safety and purity standards required for the production of the parent drug.